Study & Work (CET) Committees
Friday 18 September
CET // 17:30 - 18:15 - various locations (please check on Eventmobi)
FICPI's 23rd Open Forum is an opportunity to strengthen existing relationships and create new ones, driven by FICPI's focus on bringing independent IP attorneys from around the globe together to connect, share knowledge and grow.
Robert Watson, CET President invite all FICPI members to join the meetings of the Study and Work Committee (CET) groups at the Open Forum.
| Trade Marks Group | ||
| Designs Group | 
| International Patents |
| European Patents | 
| Pharma & Biotech Patents |
| Computer and High-Tech Patents | 
| Litigation and enforcement |
If you have questions about the work of these committees and groups, please click on the icons above to view the committee pages on the website or ask any FICPI officer at the Forum.
These group meetings provide a valuable opportunity to gain insights into FICPI's operations and connect with your co-members.
Whether you're an experienced IP attorney or new to the field, the CET offer knowledge-sharing and networking opportunities.
Robert Watson is President of FICPI’s Work and Study Commission (CET). He was previously Vice-President of the CET for 7 years, chair of the International Designs study group for 6 years, and was president of FICPI-UK (the UK national group of FICPI) from 2011 to 2015. He has represented FICPI on working meetings at the UKIPO, EPO, EUIPO and WIPO, as well as meeting with offices and law makers globally. He is also a member of the Designs and Copyright committee of CIPA.
He is a partner of the UK firm, Mewburn Ellis LLP, where he has worked since 1995, having gained a 1st class degree in Chemistry from the University of Oxford. Robert handles patent work in chemistry and materials with particular experience in the pharmaceutical, industrial chemistry and nanotech sectors.
He has also extensive experience with industrial designs. In the pharmaceutical sector he advises on the protection of drugs from initial discovery, through commercialisation to approval, including patent term extensions. In the nanotech sector, he has advised on novel nanoscale materials, and novel methods of producing graphene. He has helped numerous clients through due diligence associated with investment and acquisition.